Back to Search
Start Over
Radiolabeled HER2-directed exosomes exhibit improved cell targeting and specificity.
- Source :
-
Nanomedicine (London, England) [Nanomedicine (Lond)] 2021 Mar; Vol. 16 (7), pp. 553-567. Date of Electronic Publication: 2021 Mar 17. - Publication Year :
- 2021
-
Abstract
- Aim: Here, we established a reliable strategy for generation and characterization of targeted radiolabeled exosomes for the detection of HER2-positive cells quantitatively. Materials & methods: Targeted exosomes (T-exos) were radiolabeled by two different radiotracers, [ <superscript>99m</superscript> Tc]Tc-HMPAO or [ <superscript>111</superscript> In]In-oxine. The labeling efficiency and stability were assessed using exosome exclusive spin columns. HER2-positive and -negative cells were treated with [ <superscript>111</superscript> In]In-oxine-exosomes after 3 and 24 h. Results: [ <superscript>111</superscript> In]In-oxine labeling did not change the binding ability and general features of the exosomes. With [ <superscript>111</superscript> In]In-oxine, 70% labeling efficiency and 78% radiochemical stability over 24 h were achieved. [ <superscript>111</superscript> In]In-oxine-T-exos showed greater uptake by HER2-positive cells compared with untargeted exosomes. Conclusion: [ <superscript>111</superscript> In]In-oxine-T-exos could potentially be used as an effective imaging tool for HER2 expression.
- Subjects :
- Radiopharmaceuticals
Receptor, ErbB-2
Exosomes
Subjects
Details
- Language :
- English
- ISSN :
- 1748-6963
- Volume :
- 16
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Nanomedicine (London, England)
- Publication Type :
- Academic Journal
- Accession number :
- 33728944
- Full Text :
- https://doi.org/10.2217/nnm-2020-0408